SCHEMBL112754

SCHEMBL112754

CC(C)C1CCC(C)C(O)C1O

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.46
TRPM8 Q7Z2W7 2/20 0.46
EPHX1 P07099 1/20 0.35
FUCA1 P04066 3/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11302025 1.00 TRPA1 (0.46) TRPA1TRPM8EPHX1FUCA1ALDH1A1
SCHEMBL11304709 1.00 TRPA1 (0.46) TRPA1TRPM8EPHX1FUCA1ALDH1A1
SCHEMBL15454324 1.00 TRPA1 (0.46) TRPA1TRPM8EPHX1FUCA1ALDH1A1
SCHEMBL15462830 1.00 TRPA1 (0.46) TRPA1TRPM8EPHX1FUCA1ALDH1A1
SCHEMBL25365753 0.83 TRPA1 (0.45) TRPA1TRPM8EPHX1
SCHEMBL12166525 0.83 TRPA1 (0.45) TRPA1TRPM8EPHX1
SCHEMBL4640205 0.83 TRPA1 (0.45) TRPA1TRPM8EPHX1
SCHEMBL875599 0.79 TRPA1 (0.42) TRPA1TRPM8EPHX1
SCHEMBL875598 0.79 TRPA1 (0.42) TRPA1TRPM8EPHX1
SCHEMBL21630080 0.78 TRPA1 (0.45) TRPA1TRPM8EPHX1FUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163006-A1 New Coolants, and Preparations Containing Same SYMRISE AG (DE) 2025-05-22 US claimed
US-20250066320-A1 Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same SYMRISE AG (DE) 2025-02-27 US claimed
WO-2025026525-A1 HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS SYMRISE AG (DE) 2025-02-06 WO claimed
US-20250032500-A1 REVITALIZING EYE DROPS REVITALIZE ENERGY INC (US) 2025-01-30 US claimed
EP-4469439-A1 NEW COOLANTS, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2024-12-04 EP claimed
CN-118984825-A Novel cooling agent and preparation containing same 西姆莱斯股份公司 2024-11-19 CN claimed
EP-4452941-A1 ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME Symrise AG (DE) 2024-10-30 EP claimed
EP-4442241-A2 RETINOL REPLACEMENT IN SKIN TREATMENT Symrise AG (DE) 2024-10-09 EP claimed
EP-3773445-B1 RETINOL REPLACEMENT IN SKIN TREATMENT SYMRISE AG (DE) 2024-07-24 EP claimed
US-20240058259-A1 COMPOSITIONS COMPRISING ESSENTIAL OILS FIRMENICH SA (CH) 2024-02-22 US claimed
US-20070148103-A1 Compositions providing a heating sensation for oral or dermal delivery CADBURY ADAMS USA, LLC. 2007-06-28 US claimed
WO-2007062957-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING SYMRISE GMBH & CO. KG (DE) 2007-06-07 WO claimed
WO-2006127738-A9 COMPRESSIBLE CHEWING GUMS FOR DELIVERY OF ACTIVES CADBURY ADAMS USA LLC (US) 2007-05-31 WO claimed
EP-1446019-B1 WATER CONTINUOUS FOOD PRODUCT WITH COOLING FLAVOUR UNILEVER NV (NL) 2007-03-14 EP claimed
WO-2006127740-A2 INDICIA-BEARING PACKAGE FOR DELIVERY SYSTEMS FOR MANAGING RELEASE OF SWEETENERS, SENSATES, FUNCTIONAL INGREDIENTS, FOOD ACIDS AND FLAVORS IN A COMPRESSIBLE GUM SYSTEM CADBURY ADAMS USA LLC (US) 2006-11-30 WO claimed
WO-2006127738-A2 COMPRESSIBLE CHEWING GUMS FOR DELIVERY OF ACTIVES CADBURY ADAMS USA LLC (US) 2006-11-30 WO claimed
US-20050013846-A1 Water continuous food product with cooling flavour UNILEVER BESTFOODS, NORTH AMERICA, DIVISION OF CONOPCO, INC. 2005-01-20 US claimed
US-6838106-B2 Warming composition for food and drink or for oral care preparation TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-01-04 US claimed
EP-1446019-A1 WATER CONTINUOUS FOOD PRODUCT WITH COOLING FLAVOUR UNILEVER N.V. (NL) 2004-08-18 EP claimed
WO-2003043431-A1 WATER CONTINUOUS FOOD PRODUCT WITH COOLING FLAVOUR UNILEVER N.V. (NL) 2003-05-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070148103-A1 Compositions providing a heating sensation for oral or dermal delivery TAS2R8, TAS2R60, TAS2R20 TRPA1 37/4885TRPM8 25/4885EPHX1 3821/4885
US-20250066320-A1 Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same TAS2R5, TAS2R7, TAS2R8 TRPA1 1499/4885TRPM8 363/4885EPHX1 2617/4885
US-20250163006-A1 New Coolants, and Preparations Containing Same TTR, TAS2R5, TAS2R50 TRPA1 185/4885TRPM8 152/4885EPHX1 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.